Kiran Mazumdar-Shaw, Chairman of the company, expects the company to soon win approval in the US as well.
Shares of largecap and midcap pharmas gained strength on Wednesday, up 1-5 percent intraday on getting approval from US Food and Drug Administration (USFDA) for cholesterol and alzheimer drugs.